^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    SZ003

    i
    Other names: SZ003
    Associations

    News

    Trials
    Company:
    Guangdong ProCapZoom Biosci
    Drug class:
    NK cell stimulant
    Related drugs:
    Associations

    News

    Trials
    10ms
    Single-arm, Open-label Clinical Study of SZ003 in the Treatment of Advanced Hepatocellular Carcinoma (clinicaltrials.gov)
    P=N/A, N=8, Terminated, Shantou University Medical College | N=12 --> 8 | Trial completion date: May 2025 --> Sep 2024 | Recruiting --> Terminated | Trial primary completion date: May 2025 --> Sep 2024; Failed to recruit more volunteers
    Enrollment change • Trial completion date • Trial termination • Trial primary completion date
    |
    GPC3 (Glypican 3)
    |
    SZ003
    over1year
    Single-arm, Open-label Clinical Study of SZ003 in the Treatment of Advanced Hepatocellular Carcinoma (clinicaltrials.gov)
    P=N/A, N=12, Recruiting, Shantou University Medical College | Not yet recruiting --> Recruiting
    Enrollment open • Metastases
    |
    GPC3 (Glypican 3)
    |
    SZ003
    over2years
    Single-arm, Open-label Clinical Study of SZ003 in the Treatment of Advanced Hepatocellular Carcinoma (clinicaltrials.gov)
    P=N/A, N=12, Not yet recruiting, Shantou University Medical College
    New trial
    |
    GPC3 (Glypican 3)
    |
    SZ003